Fact Sheet for Healthcare Providers: Anti-SARS-CoV-2 Rapid Test –Autobio Diagnostics Co., Ltd.

Source: U.S. Food and Drug Administration (FDA). Published: 4/24/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Anti-SARS-CoV-2 Rapid Test, which received an Emergency Use Authorization from the Food and Drug Administration on April 24, 2020. The Anti-SARS-CoV-2 Rapid Test can be ordered by a healthcare provider to detect if there has been an adaptive immune response to COVID-19, indicating a recent or prior infection. (PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news